The pro domain of pre-pro-transforming growth factor beta 1 when independently expressed is a functional binding protein for the mature growth factor.

Transforming growth factor beta 1 (TGF-beta 1) is proteolytically derived from the carboxyl terminus of a 390 amino acid precursor molecule termed pre-pro-TGF-beta 1. Previous studies have suggested that the pro piece of pre-pro-TGF-beta 1 may play an important role in the formation of an inactive, latent complex. These latent forms are thought to be important in the regulation of TGF-beta 1 activity. To understand this latent complex in more detail, we have expressed the pro domain of pre-pro-TGF-beta 1 in tissue culture cells independent of the mature growth factor. A stop codon was genetically engineered into the cDNA of pre-pro-TGF-beta 1 by changing the Arg-278 codon from CGA to the STOP codon TGA. The resulting protein is truncated just prior to the amino-terminal Ala residue of the mature growth factor. Transient expression studies and immunoblotting indicate that this pro piece is readily made and secreted by the COS-1 cells; the major form of the expressed pro piece, when analyzed by SDS-polyacrylamide gel electrophoresis, behaves as a disulfide-linked dimer (Mr 80,000). Bioassays, using mink lung indicator cells, reveal that the pro domain forms an inactive complex with exogenously added mature TGF-beta 1. Treatment of this complex with heat or acid results in the release of active TGF-beta 1, indicating an in vitro structure similar to natural, latent TGF-beta 1 complexes. The pro piece from TGF-beta 1 was also found to form latent structures with two closely related family members, TGF-beta 1.2 and TGF-beta 2.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  L. Madisen,et al.  Transforming growth factor-beta 2: cDNA cloning and sequence analysis. , 2009, DNA.

[2]  A. Brunner,et al.  Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor beta 1 precursor. Expression and characterization of mutant proteins. , 1989, The Journal of biological chemistry.

[3]  A. Brunner,et al.  Transforming growth factor beta 1: importance of glycosylation and acidic proteases for processing and secretion. , 1989, Molecular endocrinology.

[4]  P. Jullien,et al.  Acidic cellular environments: Activation of latent tgf‐β and sensitization of cellular responses to tgf‐β and egf , 1989 .

[5]  L. Madisen,et al.  Expression and Characterization of Recombinant TGF-β2 Proteins Produced in Mammalian Cells , 1989 .

[6]  C. Heldin,et al.  Role for carbohydrate structures inTGF-β1 latency , 1989, Nature.

[7]  P. Segarini,et al.  Binding of transforming growth factor-beta to cell surface proteins varies with cell type. , 1989, Molecular endocrinology.

[8]  M. Sporn,et al.  Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding transforming growth factor beta 4 from chicken embryo chondrocytes. , 1988, Molecular endocrinology.

[9]  J. Massagué,et al.  The transforming growth factor-beta receptor type III is a membrane proteoglycan. Domain structure of the receptor. , 1988, The Journal of biological chemistry.

[10]  A. Brunner,et al.  Identification of mannose 6-phosphate in two asparagine-linked sugar chains of recombinant transforming growth factor-beta 1 precursor. , 1988, The Journal of biological chemistry.

[11]  H. Marquardt,et al.  Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide , 1988, Molecular and cellular biology.

[12]  P. ten Dijke,et al.  Identification of another member of the transforming growth factor type beta gene family. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Segarini,et al.  The high molecular weight receptor to transforming growth factor-beta contains glycosaminoglycan chains. , 1988, The Journal of biological chemistry.

[14]  Sporn,et al.  Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. , 1988, The Journal of biological chemistry.

[15]  K. Miyazono,et al.  Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. , 1988, The Journal of biological chemistry.

[16]  H. Moses,et al.  Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium , 1988, The Journal of cell biology.

[17]  Jonathan A. Cooper,et al.  Recombinant type 1 transforming growth factor beta precursor produced in Chinese hamster ovary cells is glycosylated and phosphorylated , 1988, Molecular and cellular biology.

[18]  J. Sayers,et al.  5'-3' exonucleases in phosphorothioate-based oligonucleotide-directed mutagenesis. , 1988, Nucleic acids research.

[19]  M. Sporn,et al.  Complementary deoxyribonucleic acid cloning of bovine transforming growth factor-beta 1. , 1987, Molecular endocrinology.

[20]  A. Brunner,et al.  Type 1 transforming growth factor beta: amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells , 1987, Molecular and cellular biology.

[21]  G. Plowman,et al.  Cloning and Sequence Analysis of Simian Transforming Growth Factor-β cDNA , 1987 .

[22]  H. Marquardt,et al.  Human transforming growth factor type beta 2: production by a prostatic adenocarcinoma cell line, purification, and initial characterization. , 1987, Biochemistry.

[23]  B. Seed,et al.  Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Coffey,et al.  Transforming growth factors and control of neoplastic cell growth , 1987, Journal of cellular biochemistry.

[25]  F. Eckstein,et al.  Inhibition of restriction endonuclease Nci I cleavage by phosphorothioate groups and its application to oligonucleotide-directed mutagenesis. , 1986, Nucleic acids research.

[26]  M. Sporn,et al.  Transforming growth factor-beta: biological function and chemical structure. , 1986, Science.

[27]  A. Rizzino,et al.  Preparation and binding of radioactively labeled porcine transforming growth factor type beta. , 1986, Biochemical and biophysical research communications.

[28]  E. Chen,et al.  The murine transforming growth factor-beta precursor. , 1986, The Journal of biological chemistry.

[29]  D. Lawrence,et al.  Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions , 1985 .

[30]  Anita B. Roberts,et al.  Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells , 1985, Nature.

[31]  J. Massagué,et al.  Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. , 1985, The Journal of biological chemistry.

[32]  D. Lawrence,et al.  Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F. , 1984, Cancer research.

[33]  H. Moses,et al.  Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Sporn,et al.  Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. , 1984, The Journal of biological chemistry.

[35]  H. Neurath,et al.  Evolution of proteolytic enzymes. , 1984, Science.

[36]  F. Sanger,et al.  A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. , 1975, Journal of molecular biology.

[37]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[38]  M. Sporn,et al.  Recombinant TGF-β1 is Synthesized as a Two-Component Latent Complex that Shares Some Structural Features with the Native Platelet Latent TGF-β1 Complex , 1989 .

[39]  M. Sporn,et al.  Complementary deoxyribonucleic acid cloning of a novel transforming growth factor-beta messenger ribonucleic acid from chick embryo chondrocytes. , 1988, Molecular endocrinology.

[40]  S. Hanks,et al.  Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Sporn,et al.  Transforming growth factor beta. , 1988, Advances in cancer research.

[42]  B. Seed.  An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2 , 1987, Nature.